Alcami Corporation, a contract development and manufacturing organization (CDMO), has appointed pharmaceutical industry ...
The U.S. Food and Drug Administration (FDA) has granted Fast Track Designation (FTD) to CUSP06, a Cadherin-6 targeting ...
To support the development of next-gen therapies, including GLP-1 drugs for diabetes and obesity.
The FDA has granted Fast Track Designation to Lundbeck’s investigational drug, amlenetug, a potential new treatment option targeting Multiple System Atrophy (MSA).
Alloy Therapeutics Inc., a biotechnology ecosystem company, has joined forces with Pfizer Inc., to develop a new platform ...
Oramed Pharmaceuticals Inc., a clinical-stage pharmaceutical company focused on the development of oral drug delivery ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results